Haplotype-based case-control study of estrogen receptor a (ESR1) gene and pregnancy-induced hypertension

Hypertension Research

Volumn 31, Issue 2, 2008, Pages 221-228

  Tamura, Masaaki ^a   Nakayama, Tomohiro ^a   Sato, Ichiro ^a   Sato, Naoyuki ^a   Izawa, Noriko ^a   Hishiki, Mikano ^a   Mizutani, Yoshihiro ^a   Furuya, Kiyohide ^a   Yamamoto, Tatsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Association study; Estrogen receptor; Haplotype; Polymorphism; Pregnancy induced hypertension

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ADULT; ALLELE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; FEMALE; HAPLOTYPES; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY;

EID: 41549166779     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.221     Document Type: Article

References (35)

1. Roberts JM, Cooper DW: Pathogenesis and genetics of preeclampsia. Lancet 2001; 357: 53-56.
2. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T: Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997; 34: 525-526.
3. Yamada N, Arinami T, Yamakawa-Kobayashi K, et al: The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. J Hum Genet 2000; 45: 138-141.
4. Gurdol F, Isbilen E, Yilmaz H, Isbir T, Dirican A: The association between preeclampsia and angiotensin-converting enzyme insertion/ deletion polymorphism. Clin Chim Acta 2004; 34: 127-131.
5. Malina AN, Laivuori HM, Agatisa PK, et al: The Trp64Arg polymorphism of the beta3-adrenergic receptor is not increased in women with preeclampsia. Am J Obstet Gynecol 2004; 190: 779-783.
6. Maruyama A, Nakayama T, Furuya K, Mizutani Y, Yamamoto T: Association study between the human Renin gene and preeclampsia. Hypertens Pregnancy 2005; 24: 39-48.
7. Sumino H, Ichikawa S, Ohyama Y, et al: Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype. Hypertens Res 2003; 26: 53-58.
8. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889-895.
9. Walter P, Green S, Greene G, et al: Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci U S A 1985; 82: 7889-7893.
10. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-1811.
11. Mendelsohn ME: Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002; 89 (12 Suppl): 12E-18E.
12. Mishell DR Jr, Mendelsohn ME: Introduction: the role of hormone replacement therapy in prevention and treatment of cardiovascular disease in postmenopausal women. Am J Cardiol 2002; 89 (12 Suppl): IE-4E.
13. Pare G, Krust A, Karas RH, et al: Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 2002; 90: 1087-1092.
14. Karas RH, Schulten H, Pare G, et al: Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res 2001; 89: 534-539.
15. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20 (1): IX-XIV.
16. Sato I, Nakayama T, Maruyama A, et al: Study of association between hypertensive disorders of pregnancy and the human coagulation factor XI gene. Hypertens Pregnancy 2006; 25: 21-31.
17. Nakayama T, Soma M, Rahmutula D, Ozawa Y, Kanmatsuse K: Isolation of the 5′-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction. Med Sci Monit 2001; 7: 345-349.
18. Kobayashi Y, Nakayama T, Sato N, Izumi Y, Kokubun S, Soma M: Haplotype-based case-control study of adrenomedullin genes on proteinuria in the subjects with essential hypertension. Hypertens Res 2005; 28: 229-236.
19. Morita A, Nakayama T, Doha N, Hinohara S, Soma M: Polymorphism of the C reactive protein gene is related to serum CRP level and arterial pulse wave velocity in healthy elderly Japanese. Hypertens Res 2006; 29: 323-331.
20. Dempster AP, Laird NM, Rubin DB: Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc 1977; 39: 1-22.
21. 2 receptor gene and susceptibility to cerebral infarction. Hypertens Res 2006; 29: 665-671.
22. Burl VL, Whelton P, Roccella EJ, et al: Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995: 25: 305-313.
23. August P, Oparil S: Commentary: hypertension in women. J Clin Endocrinol Metab 1999; 84: 1862-1866.
24. Calhoun DA, Oparil S: The sexual dimorphism of high blood pressure. Cardiol Rev 1998; 6: 356-363.
25. 2+ release induced by thromboxane A2 in porcine coronary artery. Circulation 1995; 91: 2619-2626.
26. Morey AK, Razandi M, Pedram A, Hu RM, Prins BA, Levin ER: Oestrogen and progesterone inhibit the stimulated production of endothelin-1. Biochem J 1998; 330: 1097-1105.
27. Oertel GW, West CD, Eik-Nes KB: Isolation and identification of estrone, estradiol and estriol in human pregnancy plasma. J Clin Endocrinol Metab 1959; 19: 1619-1625.
28. Zhu Y, Bian Z, Lu P, et al: Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002; 295: 505-508.
29. Maruyama A, Nakayama T, Sato N, Mizutani Y, Furuya K, Yamamoto T: Association study using single nucleotide polymorphisms in the estrogen receptor beta (ESR2) gene for preeclampsia. Hypertens Res 2004; 27: 903-909.
30. Lehtimaki T, Kunnas TA, Mattila KM, et al: Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J Mol Med 2002; 80: 176-180.
31. Shearman AM, Cupples LA, Demissie S, et al: Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 2003; 290: 2263-2270.
32. Malamitsi-Puchner A, Tziotis J, Evangelopoulos D, et al: Gene analysis of the N-terminal region of the estrogen receptor alpha in preeclampsia. Steroids 2001; 66: 695-700.
33. Leeners B, Rath W, Kuse S, Irawan C, Imthurn B, Neumaier-Wagner P: BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy. Clin Sci (Lond) 2006; 111: 81-86.
34. Bodnar LM, Catov JM, Klebanoff MA, Ness RB, Roberts JM: Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 2007; 18: 234-239.
35. Morris RW, Kaplan NL: On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221-233.